Addictive behaviors and addiction-prone personality traits: Associations with a dopamine multilocus genetic profile

Addictive Behaviors

Volumn 38, Issue 7, 2013, Pages 2306-2312

  Davis, Caroline ^a   Loxton, Natalie J ^b  

^a YORK UNIVERSITY   (Canada)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Addictive behaviors; Dopamine; Multilocus genetic profile; Personality

Indexed keywords

ANKYRIN REPEAT AND KINASE DOMAIN CONTAINING 1 PROTEIN; DOPAMINE 2 RECEPTOR; PROTEIN; UNCLASSIFIED DRUG;

ADDICTION; ADULT; ALLELE; ARTICLE; FEMALE; GENE DELETION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSONALITY; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; BEHAVIOR, ADDICTIVE; DOPAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MULTILOCUS SEQUENCE TYPING; PERSONALITY; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84876396014     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2013.02.012     Document Type: Article

References (69)

1. Agrawal A., Lynskey M.T. Are there genetic influences on addiction: Evidence from family, adoption and twin studies. Addiction 2008, 103:1069-1081.
2. Arinami T., Gao M., Hamaguchi H., Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Human Molecular Genetics 1997, 6:577-582.
3. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology 1986, 51:1173-1182.
4. Berglund K., Roman E., Balldin J., Berggren U., Eriksson M., Gustavsson P., et al. Do men with excessive alcohol consumption and social stability have an addictive personality?. Scandinavian Journal of Psychology 2011, 52:257-260.
5. Blum K., Braverman E.R., Holder J.M., Lubar J.F., Monastra V.J., Miller D., et al. Reward deficiency syndrome: A biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. Journal of Psychoactive Drugs 2000, 32:1-112.
6. Blum K., Chen A.L.C., Giordano J., Borsten J., Chen T.J.H., Hauser M., et al. The addictive brain: All roads lead to dopamine. Journal of Psychoactive Drugs 2012, 44:134-143.
7. Buscemi L., Turchi C. An overview of the genetic susceptibility to alcoholism. Medicine, Science and the Law 2011, 51:S2-S6.
8. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. American Journal of Human Genetics 2004, 75:807-821.
9. Christo G., Jones S.L., Haylett S., Stephenson G.M., Lefever R.M.H., Lefever R. The Shorter PROMIS Questionnaire: Further validation of a tool for simultaneous assessment of multiple addictive behaviours. Addictive Behaviors 2003, 28:225-248.
10. Clarke D. Gambling and the trait of addiction in a sample of New Zealand university students. New Zealand Journal of Psychology 2003, 32:39-48.
11. Dagher A., Robbins T.W. Personality, addiction, dopamine: Insights from Parkinson's Disease. Neuron 2009, 61:502-510.
12. Davis C., Curtis C., Levitan R.D., Kaplan A.S., Carter J.C., Kennedy J.L. Evidence that food addiction is a valid phenotype of obesity. Appetite 2011, 57(3):711-717.
13. Davis C., Levitan R.D., Yilmaz Z., Kaplan A.S., Carter J.C., Kennedy J.L. Binge eating disorder and the dopamine D2 receptor: Genotypes and sub-phenotypes. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2012, 38:328-335.
14. Dawe S., Loxton N.J. The role of impulsivity in the development of substance use and eating disorders. Neuroscience and Biobehavioral Reviews 2004, 28:343-351.
15. Derringer J., Krueger R.F., Dick D.M., Saccone S., Grucza R.A., Agrawal A., et al. Predicting sensation seeking from dopamine genes: A candidate-system approach. Psychological Science 2010, 2:1282-1290.
16. Dissabandara L.O., Loxton N.J., Dias S.R., Daglish M., Stadlin A. Testing the fear and anxiety distinction in the BIS/BAS scales in community and heroin-dependent samples. Personality and Individual Differences 2012, 52:888-892.
17. Enoch M.-E. The influence of gene-environment interactions on the development of alcoholism and drug dependence. Current Psychiatry Reports 2012, 14:150-158.
18. Eysenck H.J. Addiction, personality and motivation. Human Psychopharmacology: Clinical and Experimental 1997, 12:S79-S87.
19. Eysenck H.J., Eysenck S.B.G. Manual of the Eysenck Personality Questionnaire 1975, Hodder & Stoughton, London.
20. Forbes E.E., Brown S.M., Kimak M., Ferrell R.E., Ferrell R.E., Manuck S.B., et al. Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Molecular Psychiatry 2009, 14:60-70.
21. Fowler T., Lifford K., Rice F., Thapar A., Neale M.C., McBride A., et al. Exploring the relationship between genetic and environmental influences on initiation and progression of substance use. Addiction 2007, 102:413-422.
22. Genovese J.E.C., Wallace D. Reward sensitivity and substance abuse in middle school and high school students. Journal of Genetic Psychology 2007, 168:465-469.
23. Gorwood P., Le Strat Y., Ramoz N., Dubertret C., Moalic J.M., Simonneau M. Genetics of dopamine receptors and drug addiction. Human Genetics 2012, 131:803-822.
24. Gossop M.R., Eysenck S.B.G. A further investigation into the personality of drug addicts in treatment. British Journal of Addiction 1980, 75:305-311.
25. Grandy D.K., Zhang Y., Civello O. PCR detection of the TaqQ RFLP at the DRD2 locus. Human Molecular Genetics 1993, 2:2197.
26. Hayes A.F. Beyond Baron and Kenny: Statistical mediation analysis in the new millennium. Communication Monographs 2009, 76:408-420.
27. Haylett S.A., Stephenson G.M., Lefever R.M.H. A study of addictive orientations using the Shorter-PROMIS Questionnaire. Addictive Behaviors 2004, 29:61-71.
28. Hirvonen M.M., Laakso A., Nagren K., Rinne J.O., Pohjalainen T., Hietala J. C957 polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Molecular Psychiatry 2004, 9:1060-1061.
29. Hirvonen M.M., Laakso A., Nagren K., Rinne J.O., Pohjalainen T., Hietala J. C957 polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Molecular Psychiatry 2005, 9:1060.
30. Hirvonen M.M., Laakso A., Nagren K., Rinne J.O., Pohjalainen T., Hietala J. C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse 2009, 63:907-912.
31. Jonsson E.G., Nothen M.M., Grunhage F., Farde L., Nakashima Y., Propping P., et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Molecular Psychiatry 1999, 4:290-296.
32. Kagan D.M., Albertson L.M. Scores on MacAndrew Factors-Bulimics and other addictive populations. International Journal of Eating Disorders 1986, 5:1095-1101.
33. Koob G.F., Simon E.J. The neurobiology of addiction: Where we have been and where we are going. Journal of Drug Issues 2009, 39:115-132.
34. Lahiri D.K., Nurnburger J.I. A rapid non-enzymatic method for the preparation of HMV DNA from blood for RFLP analysis. Nucleic Acids Research 1991, 19:5444.
35. 2 dopamine receptor A1 allele with alcoholism: Medical severity of alcoholism and type of controls. Biological Psychiatry 1997, 41:386-393.
36. Le Foll B., Gallo A., Le Strat Y., Lu L., Gorwood P. Genetics of dopamine receptors and drug addiction: A comprehensive review. Behavioural Pharmacology 2009, 20:1-17.
37. Lent M.R., Swencionis C. Addictive personality and maladaptive eating behaviours in adults seeking bariatric surgery. Eating Behaviors 2012, 13:67-70.
38. Lester D., Narkunski A. Methodological problems in describing addictive personality. Psychological Reports 1978, 43:134.
39. Loxton N.J., Nguyen D., Casey L., Dawe S. Reward drive, rash impulsivity and punishment sensitivity in problem gamblers. Personality and Individual Differences 2008, 45:167-173.
40. Loxton N.J., Wan V.L.-N., Ho A.M.-C., Cheung B.K.-L., Tam N., Leung F.Y.K., et al. Impulsivity in Hong Kong-Chinese club-drug users. Drug and Alcohol Dependence 2008, 95:81-89.
41. Lyvers M., Czerczyk C., Follent A., Lodge P. Disinhibition and reward sensitivity in relation to alcohol consumption by university undergraduates. Addiction Research & Theory 2009, 17(6):668-677.
42. MacAndrew C. The differentiation of male alcoholic outpatients from non-alcoholic male psychiatric outpatients by means of the MMPI. Quarterly Journal of Studies on Alcohol 1965, 26:238-246.
43. Mill J., Asherson P., Browes C., D'Souza I.J., Craig I. Expression of the dopamine transporter gene is regulated the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. American Journal of Medical Genetics 2002, 114:975-979.
44. Nathan P.E. The addictive personality is the behavior of the addict. Journal of Consulting and Clinical Psychology 1988, 56:183-188.
45. Nees F., Tzschoppe J., Patrick C.J., Vollstadt-Klein S., Steiner S., Poustka L., et al. Determinants of early alcohol use in healthy adolescents: The differential contribution of neuroimaging and psychological factors. Neuropsychopharmacology 2012, 37:986-995.
46. Nestor I., Hester R., Garavan H. Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users. NeuroImage 2010, 49:1133-1143.
47. Nikolova Y.S., Ferrell R.E., Manuck S.B., Hariri A.R. Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity. Neuropsychopharmacology 2011, 36:1940-1947.
48. Noble E.P. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2003, 116:103-125.
49. Noble E.P., Blum K., Ritchie T., Montgomery A., Sheridan P.J. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Archives of General Psychiatry 1991, 49:648-654.
50. Noble E.P., Gottschalk L.A., Fallon J.H., Ritchie T.L., Wu J.C. D2 dopamine receptor polymorphism and brain regional glucose metabolism. American Journal of Medical Genetics 1997, 74:162-166.
51. Ogden M.E., Dundas M., Bhat A.V. Personality differences among alcoholic misusers in community treatment. Personality and Individual Differences 1988, 10:265-267.
52. Olsen C.M. Natural rewards, neuroplasticity, and non-drug addictions. Neuropharmacology 2011, 61:1109-1122.
53. Parsian A., Cloninger C.R., Zhang Z.H. Functional variant in the DRD2 receptor promoter region and subtypes of alcoholism. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2000, 96B:407-411.
54. Plomin R., Haworth C.M.A., Davis O.S.P. Common disorders are quantitative traits. Nature Reviews. Genetics 2009, 10:872-878.
55. Poelen E.A.P., Derks E.M., Engels R.C.M.E., van Leeuwe J.F.J., Scholte R.H.J., Willemsen G., et al. The relative contribution of genes and environment to alcohol use in early adolescents: Are similar factors related to the initiation of alcohol use and frequency of drinking?. Alcoholism, Clinical and Experimental Research 2008, 6:975-982.
56. Poletti M., Bonuccelli U. Personality traits in patients with Parkinson's disease: Assessment and clinical implications. Journal of Neurology 2012, 259:1029-1038.
57. Preacher K.J., Hayes A.F. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behavior Research Methods, Instruments, & Computers 2004, 36:717-731.
58. Preacher K.J., Hayes A.F. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behavior Research Methods 2008, 40:879-891.
59. Stuber G.D., Britt J.P., Bonci A. Optogenetic modulation of neural circuits that underlie reward seeking. Biological Psychiatry 2012, 71:1061-1067.
60. VanKaam A. The addictive personality. Humanitas 1965, 1:183-193.
61. VanNess S.H., Owens M.J., Kilts C.D. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genetics 2005, 5.
62. Voisey J., Swagell C.D., Hughes I.P., van Daal A., Noble E.P., Lawford B.D., et al. A DRD2 and ANKK1 haplotype is associated with nicotine dependence. Psychiatry Research 2012, 196:285-289.
63. Volkow N.D., Muenke M. The genetics of addiction. Human Genetics 2012, 131:773-777.
64. Volkow N.D., Wang G.-J., Fowler J.S., Logan J., Gatley S.J., Gifford A., et al. Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D-2 receptor levels. American Journal of Psychiatry 1999, 156:1440-1443.
65. Vrieze S.I., McGue M., Iacono W.G. The interplay of genes and adolescent development in substance abuse disorders: Leveraging finds from GWAS meta-analyses to test developmental hypotheses about nicotine consumption. Human Genetics 2012, 131:791-801.
66. Weinshilboum R.M., Otterness D.M., Szumlanski C.L. Methylation pharmacogenetics: Catechol-O-methyltransferese, thiopurine methytransferese, and histamine N-methyltransferese. Annual Review of Pharmacology and Toxicology 1999, 39:19-52.
67. White V.M., Hopper J.L., Wearing A.J., Hill D.J. The role of genes in tobacco smoking during adolescence and young adulthood: A multivariate behavior genetic investigation. Addiction 2003, 98:1087-1100.
68. 108/158Met polymorphism effects on emotional brain function and negativity bias. NeuroImage 2010, 53:918-925.
69. Zhang Y., Bertolino A., Fazio L., Blasi G., Rampino A., Romano R., et al. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proceedings of the National Academy of Sciences 2007, 104:20552-20557.